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Objectives: To assess myocardial function and presence of pulmonary hypertension (PH) 
using both tissue Doppler imaging (TDI) and conventional echocardiography in preterm 
infants <32weeks gestation with chronic lung disease (CLD). 
Design: Prospective observational study. 
Setting: Tertiary neonatal intensive care unit.  
Patients: Three groups of preterm infants were recruited. Group 1 - CLD receiving positive 
pressure airway support [including high-flow humidified nasal cannula oxygen] (n=25). 
Group 2 - CLD receiving low-flow nasal oxygen (n=25) and group 3 no CLD (n=22). 
Methods: Echocardiography was performed around 36 weeks corrected gestational age. 
Myocardial function and PH were assessed using both conventional (left ventricular 
fractional shortening [LVFS] and left ventricular output [LVO], tricuspid regurgitation and 
ventricular septal flattening) and TDI techniques (myocardial velocities, myocardial 
performance index [MPI] and right ventricular isovolumetric relaxation time [RV-IVRT]). 
Results: The MPI of right (RV) and left (LV) ventricles was significantly higher in CLD infants: 
mean RV MPI group 1 – 0.79, group 2 – 0.65 and group3 – 0.52. LV MPI: group 1 – 0.77, 
group 2 – 0.70 and group 3 – 0.45. There was a trend towards higher MPIs in group 1 
compared to group 2. LVFS and LVO were similar across all three groups.  
RV-IVRT was also significantly higher in infants with CLD infants (group 1 – 0.06 seconds, 
group 2 – 0.06 seconds and group 3 – 0.05 seconds). PH was not detected by conventional 
echocardiography.  
Conclusion: Infants with CLD have evidence of relative biventricular dysfunction and higher 
pulmonary arterial blood pressure as demonstrated by TDI which were not detected by 

















Chronic lung disease of prematurity (CLD) - defined as a persisting need for respiratory 
support and/or supplemental oxygen at 36 weeks corrected gestational age (CGA) - is the 
commonest respiratory disease in infancy (1). CLD usually occurs in infants born at <32 
weeks gestational age (GA)  and can lead to persisting abnormalities of  lung function 
through to adolescence.(1,2,3) Although most complications of CLD are respiratory, 
cardiovascular complications such as  pulmonary hypertension (PH) (4,5) and myocardial 
dysfunction(6,7,8) are well recognised. CLD is the commonest respiratory cause of PH in 
children(9) and although the precise incidence in CLD is not known, single centre studies 
report PH in 20-37% of preterm babies (<32weeks GA).(9-11) Cardiac catheterisation 
remains the gold standard for diagnosing PH in children,(9) however, conventional 
echocardiographic measures such as tricuspid regurgitation velocity (TR) are widely used to 
try to identify  PH in the neonatal period(5) but the accuracy of TR in this respect is 
uncertain.  
Tissue Doppler imaging (TDI) is a validated echocardiographic technique for evaluating 
myocardial function in preterm infants.(12-14)  By analysing the Doppler signals from the 
myocardium, systolic and diastolic velocities representing relative myocardial function can 
be measured (low myocardial velocities indicating myocardial dysfunction). Myocardial 
performance index (MPI), a measure of systolic and diastolic myocardial function is also 
calculated (a higher MPI indicating myocardial dysfunction). Pulmonary arterial blood 
pressure can also be assessed indirectly using TDI by measuring right ventricular 
isovolumetric relaxation time (RV-IVRT: with a longer RV-IVRT indicating higher pulmonary 
blood pressure).(6, 15-18)  
Previous reports of TDI in the assessment of myocardial function in preterm infants with 
CLD prior to discharge are limited to one small study (21 infants) and a case report.(6,7)  
The aims of this study were (i) to evaluate myocardial function in preterm infants (<32weeks 
GA) diagnosed with CLD using both TDI and conventional echocardiographic assessment of 
left ventricular function (fractional shortening [LVFS] and left ventricular output [LVO]), and 
(ii) to assess the presence of pulmonary hypertension (PH) using conventional 
echocardiographic measures (tricuspid regurgitation [TR] and ventricular septal flattening) 
and TDI-derived RV-IVRT. 
METHODS: 
All preterm infants (<32 weeks GA) on the tertiary neonatal unit at Birmingham Women’s 
Hospital were eligible for inclusion. CLD was defined as persisting need for respiratory 
support and / or supplemental oxygen in preterm infants at 36 weeks CGA. Infants with CLD 
were classified into 2 groups based on the level of respiratory support - group 1: infants with 
CLD needing positive airway pressure support (CPAP, biphasic CPAP (BiPAP) and High-flow 
humidified nasal oxygen), group 2 included infants with CLD needing low-flow nasal oxygen. 
Group 3 included preterm infants without CLD (controls). Infants with major congenital 
malformations including congenital heart defects were excluded. Ethical approval, 
institutional research and development approval and written informed parental consent 
were obtained prior to recruitment.  
A single echocardiogram was performed by the same investigator (PKY) on all infants 
between 36+0 and 37+2 weeks CGA using a Philips HD11xe ultrasound system with a S12-
4MHz transducer (Philips Healthcare, Best, The Netherlands).  
Conventional echocardiographic assessment: 
Normal cardiac anatomy was ascertained and the presence or absence of a PDA was 
determined using a modified high parasternal long axis view (ductal view) and colour flow 
Doppler. M-mode echocardiography was used to calculate LVFS using a parasternal long-axis 
view at the level just distal to the mitral valve leaflets.(19) LVO was calculated using 
previously described technique.(20) Conventional echocardiographic assessment of PH 
using tricuspid regurgitation (TR) jet  and ventricular septal flattening was undertaken. TR 
was used as a screening tool and was classified as mild (<2m/s), moderate (2 – 2.8m/s) and 
severe (>2.8m/s). (9) Infants with severe TR and/or septal flattening were to be referred to 
paediatric cardiologists for further assessment of elevated pulmonary blood pressure. 
Tissue Doppler imaging: 
Myocardial velocities were obtained from an apical four-chamber view. A Pulse Wave 
Doppler sample gate of 0.12cm was used and an angle of insonation of <20º was maintained 
using 2D hold; the Doppler signal was not corrected. Myocardial velocity signals were 
recorded from the medial mitral (MMA) and lateral mitral (LMA) annuli representing left 
ventricular (LV) function and from the lateral tricuspid annulus (LTA) representing right 
ventricular (RV) function. Peak systolic (S′), early diastolic (E′) and late diastolic (A′) 
myocardial velocities were measured (figure 1).  MPI was calculated using the TDI wave 
forms as previously described.(21) RV-IVRT - the time interval between the end of systole 
and the beginning of diastole - was also measured (see figure 1). Offline analysis was 
performed for all measurements on the same ultrasound system and average 
measurements over 2-3 cardiac cycles were used. 
Routine clinical data, including level of respiratory support at the time of investigation were 
also collected (table 1)  
Table 1: Clinical characteristics of infants in groups 1, 2 and 3 
Clinical characteristic 
Group 1 Group 2 Group 3 
p value 
Pair wise comparisons (*) 
p value 
n = 25 n = 25 n = 22 1 vs. 2 2 vs. 3 1 vs. 3 
Gestational age wks. 
mean (SD) 27.0 (1.9) 27.2 (1.9) 28.6 (2.3) 0.021
(a) NS NS 0.028 
Birth weight gm                             
median (range) 
778 (500 - 
1640) 




(b) NS NS 0.023 
Ventilation days                               
median (range) 
79 (44 - 
125) 35 (4 - 89) 10 (1 - 64) <0.001
(b) <0.001 <0.001 <0.001 
Antenatal steroids                                     
n (%) 19 (76.0) 17 (68.0) 16 (72.7) NS
(c) - - - 
Exogenous surfactant   
n (%) 24 (96.0) 21 (84.0) 10 (45.5) <0.001
(c) NS 0.008 0.002 
Pharmacological 
treatment for PDA n(%) 10 (40.0) 8 (32.0) 2 (9.1) NS
(c) - - - 
Surgical ligation of PDA    
n (%) 9 (36.0) 2 (8.0) 0 (0) 0.014
(c) 0.051 NS 0.006 
Postnatal 
Dexamethasone  n (%) 13 (52.0) 1 (4.0) 0 (0) <0.001
(c) <0.001 NS <0.001 
Supplemental oxygen at 
discharge   n (%) 17 (68.0) 13 (52.0) 0 (0) <0.001
(c) NS <0.001 <0.001 
(a) ANOVA test followed by Bonferroni multiple comparison tests(b) Kruskall Wallis rank test followed by Mann-Whitney U 
pairwise tests. p-values have been multiplied by three 
(c) Pearson Chi-squared test 
NS - not significant 
 
STATISTICAL ANALYSES: 
Normally distributed data are presented as Mean and SD and skewed data are presented as 
medians and ranges. Statistical analyses were performed using SPSS v20 (SPSS, Chicago, IL). 
The Shapiro-Wilk test was used to test the normality of the data. ANOVA or Kruskal-Wallis 
tests were used for comparisons involving three or more groups, depending on data 
distributions. When the analysis showed a significant result, we performed post-hoc 
multiple comparison test accounting adequately for the type I error inflation. We have used 
Bonferroni multiple range test after a significant ANOVA or multiple pairwise Mann Whitney 
U tests after a significant Kruskal-Wallis. In the latter case, we adjusted significance level to 
account for multiplicity of tests and accordingly, we multiplied pairwise comparison p-values 
by the number of tests performed. T - Student test and Mann-Whitney U test were used to 
test significance of normal and skewed data respectively where appropriate. Chi-squared 
test was used to compare categorical data. A p value of <0.05 was considered significant. 
The inter- and intra-observer reliability of TDI measurements have been previously 
established by our group and other investigators.(12-14, 22-24) Conventional 
echocardiographic and TDI measurement, if considered normal distributions, were 
compared after adjusting for gestational age and birth weight using a generalized linear 
regression model. We checked if adding these two confounders to the linear model changed 
the estimations of the differences between groups. 
RESULTS 
Seventy two preterm infants, <32 weeks GA, were recruited into the three groups. Group 1 
had 25 infants, group 2 - 25 infants and group 3 - 22 infants.(Table 1).  
Conventional echocardiographic assessment 
No significant structural heart defect was found in any infants. According to previously 
published criteria,(25) only one infant (in group 1) had a haemodynamically significant PDA. 
None had echocardiographic evidence of elevated pulmonary blood pressure (severe TR 
and/or ventricular septal flattening) requiring further cardiology assessment. Five infants 
had moderate TR (2 each in groups 1 and 2 and 1 in group 3). The remaining 67 infants 
either had mild or no TR.  LVFS and LVO did not differ significantly between the three groups 
(table 2). 
Table 2: Conventional echocardiographic and TDI measurements of cases and controls 
Clinical 
characteristic 
Group 1 Group 2 Group 3 
p value 
Pair wise comparisons 
p value 
n = 25 n = 25 n = 22 1 vs. 2 2 vs. 3 1 vs. 3 
LVFS (%) 31.3 (7.04) 35.56 (9.11) 
31.89 
(7.79) NS
(b) - - - 
LVO (ml/kg/min) 396 (88) 383(67) 400(89) NS(b) - - - 
MMA S' (cm/s) 5.45 (0.93) 5.09 (0.88) 4.92 (0.68) NS(b) - - - 
 E' (cm/s) 5.42 (1.43) 6.21 (1.40) 5.80 (0.78) NS
(b) - - - 
 A' (cm/s) 7.89 (1.79) 7.64 (1.55) 7.39 (1.75) NS
(a) - - - 
 MPI 0.74 (0.16) 0.65 (0.19) 0.47 (0.12) <0.001
(b) 0.024 <0.001 <0.001 
LMA S' (cm/s) 5.84 (0.61) 5.50 (0.87) 5.39 (0.93) NS(a) - - - 
 E' (cm/s) 6.16 (1.24) 6.97 (1.41) 7.00 (1.11) NS
(b) - - - 
 A' (cm/s) 9.26 (2.15) 8.45 (1.46) 9.32 (2.24) NS
(a) - - - 
  MPI (*) 0.77 (0.14) 0.70 (0.20) 0.45 (0.14) <0.001(a) NS <0.001 <0.001 
LTA S' (cm/s) 10.06 (2.32) 9.00 (1.31) 8.46 (1.06) 0.026(b) NS NS 0.009 
 E' (cm/s) 10.03 (1.48) 9.09 (1.82) 8.89 (1.57) NS
(a) - - - 
 A' (cm/s) 12.02 (2.43) 12.28 (1.9) 
11.95 
(2.96) NS
(a) - - - 
 MPI 0.79 (0.33) 0.65 (0.17) 0.52 (0.17) 
< 
0.001(b) NS 0.006 <0.001 
  IVRT (sec)* 0.06 (0.02) 0.06 (0.01) 0.05 (0.01) 0.001(a) NS 0.031 0.001 
(a) ANOVA test 
(b) Kruskall Wallis rank test 
(*) Remains still significant after adjusting for GA and BW 
NS - not significant; LVFS - left ventricular fractional shortening; LVO - left ventricular output; MMA - medial mitral annulus; 
LMA - lateral mitral annulus; LTA - lateral tricuspid annulus; IVRT - isovolumetric relaxation time; S' - peak systolic velocity; E' - 
early diastolic velocity; A' - late diastolic velocity; MPI - myocardial performance index. 
 
 
Tissue Doppler assessment 
Infants with CLD (groups 1 and 2) had significantly higher MPIs at all three sites and longer 
RV-IVRT compared to infants without CLD (group 3) [table 2]. Infants in group 1 had higher 
MPI compared to group 2 only at the MMA. There was no statistically significant difference 
in myocardial velocities, LMA and LTA MPIs and the RV-IVRT between groups 1 and 2 (table 
2).  
Sub-group analysis: 
We performed the following sub-group analyses among infants with CLD (groups 1 and 2): i) 
infants who received postnatal dexamethasone for the management of CLD (according to 
DART protocol) (26) were compared to those who did not, and (ii) infants discharged on 
supplemental oxygen were compared to infants breathing room air at discharge. 
Fourteen of the 50 infants with CLD received postnatal dexamethasone. Myocardial function 
assessments in these infants are shown in table 3. Infants who required dexamethasone had 
significantly higher MPIs at all three sites compared to infants who did not. No infant had 








 Table 3: Sub-group analysis: Conventional echocardiographic and TDI measurements of 
infants with CLD who received postnatal dexamethasone vs. no dexamethasone 
Clinical 
characteristic 
Desamethasone No Dexamethasone 
p value 
n = 14 n = 36 
LVFS (%) 32.2 (7.3) 33.3 (8.6) NS(a) 
LVO (ml/kg/min) 401(76) 380 (73) NS(a) 
MMA S' (cm/s) 5.52 (1.11) 5.17 (0.83) NS(b) 
 E' (cm/s) 5.15 (1.06) 6.04 (1.52) NS
(a) 
 A' (cm/s) 7.71 (1.95) 7.80 (1.58) NS
(a) 
 MPI 0.78 (0.18) 0.66 (0.17) <0,001
(b) 
LMA S' (cm/s) 5.82 (0.66) 5.61 (0.81) NS(a) 
 E' (cm/s) 6.06 (1.59) 6.72 (1.29) NS
(b) 
 A' (cm/s) 8.62 (1.96) 8.93 (1.86) NS
(a) 
  MPI 0.80 (0.14) 0.71 (0.18) <0.001(b) 
LTA S' (cm/s) 9.75 (2.20) 9.44 (1.85) NS(b) 
 E' (cm/s) 9.62 (1.66) 9.49 (1.76) NS
(a) 
 A' (cm/s) 12.06 (2.48) 12.19 (2.06) NS
(a) 
 MPI 0.83 (0.39) 0.67 (0.19) 0.015
(b) 
  IVRT (sec) 0.06 (0.02) 0.06 (0.01) NS(b) 
(a) T-student test 
(b) Mann-Whitney U test 
NS - not significant; LVFS - left ventricular fractional shortening; LVO - left ventricular output; MMA - 
medial mitral annulus; LMA - lateral mitral annulus; LTA - lateral tricuspid annulus; IVRT - isovolumetric 
relaxation time; S' - peak systolic velocity; E' - early diastolic velocity; A' - late diastolic velocity; MPI - 
myocardial performance index 
Thirty out of the 50 infants with CLD were discharged on supplemental oxygen. Myocardial 
function in these infants is shown in table 4. Those discharged on supplemental oxygen had 
significantly higher MPIs at all three sites, higher peak systolic velocities at MMA and LTA 
and lower early diastolic velocity at LMA compared to those infants who did not require 
supplemental oxygen at discharge. 
Table 4: Sub-group analysis: Conventional echocardiographic and TDI measurements of 




Oxygen at discharge No Oxygen at discharge p value 
n = 30 n = 20 
LVFS (%) 33.8 (9.1) 31.9 (7.0) NS(a) 
LVO (ml/kg/min) 426 (78) 392 (63) NS(b) 
MMA S' (cm/s) 5.45 (1.00) 4.99 (0.71) 0,026(b) 
 E' (cm/s) 5.87 (1.63) 5.70 (1.24) NS
(a) 
 A' (cm/s) 8.09 (1.96) 7.39 (1.15) NS
(a) 
 MPI 0.71 (0.19) 0.66 (0.15) <0.001
(b) 
LMA S' (cm/s) 5.58 (0.79) 5.80 (0.73) NS(a) 
 E' (cm/s) 6.24 (1.22) 7.06 (1.47) 0.020
(a) 
 A' (cm/s) 8.83 (1.68) 8.89 (2.17) NS
(a) 
  MPI 0.76 (0.15) 0.70 (0.20) <0.001(a) 
LTA S' (cm/s) 9.63 (1.79) 9.38 (2.17) 0.030(b) 
 E' (cm/s) 9.59 (1.50) 9.41 (2.08) NS
(a) 
 A' (cm/s) 12.36 (2.16) 11.82 (2.12) NS
(a) 
 MPI 0.75 (0.30) 0.67 (0.20) 0.004
(b) 
  IVRT (sec) 0.06 (0.01) 0.06 (0.01) NS(a) 
(a) T-student test 
(b) Mann-Whitney U test 
NS - not significant; LVFS - left ventricular fractional shortening; LVO - left ventricular output; 
MMA - medial mitral annulus; LMA - lateral mitral annulus; LTA - lateral tricuspid annulus; IVRT - 
isovolumetric relaxation time; S' - peak systolic velocity; E' - early diastolic velocity; A' - late 





We have used both conventional and TDI echocardiographic assessments to evaluate 
myocardial function in infants with CLD. To our knowledge, only one small study, involving 
21 preterm infants, has been previously published.(6) In the current study we have 
demonstrated that biventricular MPIs were significantly higher in preterm infants with CLD 
at 36 weeks CGA compared to those without CLD - indicating relative myocardial 
dysfunction. RV-IVRT measured using TDI was longer in CLD infants compared to those 
without CLD indicating higher pulmonary arterial pressure. However, conventional 
echocardiographic assessments of LV function were similar.  
M-mode derived LVFS is an unreliable method of assessing LV systolic function due to the 
differences in ventricular geometry (in neonates compared to adults) and non-homogeneity 
of LV wall motion.(27) A recent study in preterm infants born at <29 weeks gestation has 
also demonstrated that LVFS is unreliable during the transitional period.(28) Similarly LVO 
measurements in preterm neonates are affected by the patent fetal shunts, particularly the 
ductus arteriosus which can ‘steal’ up to 70% of the left ventricular output.(29) 
Conventional echocardiographic measures to identify PH, particularly TR, may not be very 
reliable. A recent systematic review of echocardiographic measures used to diagnose PH in 
CLD reported an inconsistent correlation between TR and PH.(30)  
TDI is an alternative technique of assessing myocardial function, and in the last decade 
various groups of investigators (including our group) have established the feasibility of 
performing TDI measurements in preterm and term infants.(12-14) Its utility has been 
studied in different preterm populations e.g. infants with haemodynamically-significant 
PDA, following surgical ligation of PDA and infants receiving blood transfusions.(22-24). TDI 
processes the Doppler signals from the myocardium and allows measurement of myocardial 
velocities during both contraction and relaxation phases.(31) Myocardial performance index 
(MPI) is a simple ratio derived from various time intervals of the cardiac cycle (figure 1) and 
provides a quantitative assessment of combined systolic and diastolic function of the 
myocardium(32); a higher MPI indicating myocardial dysfunction. Although MPI was 
originally derived from standard pulse wave Doppler velocities, it can also be derived using 
TDI waveforms and the reliability of this method has been established.(21) 
In our study, myocardial function, as assessed by the conventional methods of LVFS and 
LVO, was not different between infants in the 3 groups. Yates et al reported similar findings 
in CLD infants and hypothesised that TDI derived indices may be more sensitive than 
conventional techniques.(6) In our cohort biventricular MPIs in CLD infants requiring 
positive pressure airway support (group 1) were higher than those obtained from  CLD 
infants requiring low flow oxygen (group 2) which were higher than those from non-CLD 
infants (group 3) suggesting relative biventricular dysfunction that correlated with severity 
of CLD. Yates also found that the myocardial velocities and MPIs were abnormal in CLD 
infants, although they did not reach statistical significance.(6)  Kazanci et al also 
demonstrated higher biventricular MPIs in older infants with CLD compared to controls(8) 
and Czernik et al reported elevated RV MPIs in preterm infants with evolving CLD at 28 days 
of age.(33) These data and the current study suggest that MPI derived from TDI may be a 
more useful measure of myocardial dysfunction compared to LVFS and LVO.  
Previous studies have demonstrated that some infants with CLD have echocardiographic 
indicators of PH (10,11) which  persist until at least early childhood (34,35) and  may 
normalise by the end of first decade.(18) In this study we evaluated the most commonly 
used conventional echocardiographic measures of pulmonary hypertension i.e. TR and 
septal flattening (9) and compared them to RV-IVRT measured using TDI as an indirect 
measure of pulmonary hypertension. RV-IVRT has been shown to correlate well with 
pulmonary arterial systolic pressure in adults - the longer the IVRT higher the pulmonary 
arterial systolic pressure - and it may be more useful than measuring tricuspid regurgitant 
jet velocity (TR).(15-17) Yates et al determined RV-IVRT in infants with CLD and found an 
increasing trend with increasing severity of CLD.(6) Kazanci et al also found that infants with 
CLD had prolonged RV-IVRT compared to healthy controls.(8) In our study we have 
demonstrated that RV-IVRT is significantly prolonged in preterm infants with CLD compared 
to those without CLD. However, conventional echocardiographic measures did not indicate 
elevated pulmonary blood pressure. Our data suggest prolonged RV-IVRT may be more 
sensitive than TR and ventricular septal flattening at detecting high pulmonary pressures in 
infants with CLD. Further studies are needed to identify a threshold value for RV-IVRT that 
would identify clinically significant PH. 
Sub-group analysis showed that infants with CLD who received postnatal dexamethasone 
for the management of CLD and those requiring supplemental oxygen at discharge had 
higher MPIs.  Both these results support the hypothesis that infants with more severe CLD 
have relative myocardial dysfunction. However, larger studies are needed to evaluate the 
clinical significance of this finding.  
We found that the peak systolic myocardial velocity at LTA in group 1 infants with CLD was 
higher compared to infants without CLD. In the sub-group analyses similar higher systolic 
velocities were detected at MMA and LTA in infants who required supplemental oxygen at 
discharge. This is in contradiction to the MPI measurements.  However, this finding is in 
keeping with the study by Yates et al who also noted that the peak systolic velocities were 
higher in infants with severe CLD compared to infants with no or mild CLD. We can only 
hypothesize that the increased velocity of contraction might be an attempt by the 
myocardium to compensate for the increased pulmonary vascular resistance and this also 
warrants further investigation in larger studies. 
Other limitations to our study are, although it is the largest study to date in infants with CLD 
at 36 weeks CGA, the sample size is relatively small.  Although TDI-derived measurements 
may be more sensitive than conventional techniques in detecting myocardial dysfunction, 
they are not entirely independent of preload and after-load conditions.(23) The TDI 
measurements obtained in this study reflect myocardial motion in the longitudinal plane 
only and do not provide information about myocardial motion in other planes. We did not 
measure right ventricular output (RVO) in this study as the reproducibility is not well 
established and is more prone to error - the elasticity of the pulmonary arterial walls during 
systole, and the fact that the pulmonary valves are parallel to ultrasound beams during 
echocardiography (c.f. aortic valves which are perpendicular making measurement more 
reliable).(36)   
Using TDI-derived assessments of myocardial function, we have shown that preterm infants 
with CLD have evidence of relative biventricular dysfunction compared to those without 
CLD. TDI also identified prolongation of RV-IVRT in preterm infants with CLD inferring higher 
pulmonary arterial blood pressure in these patients. TDI-derived indices may be more 
sensitive at detecting myocardial dysfunction in CLD compared to LVFS and LVO. 
MPI and RV-IVRT derived from TDI measurements may offer neonatologists a novel way of 
monitoring infants with CLD. 




What is already known on this subject: 
1. Tissue Doppler imaging is feasible in preterm infants 
2. Neonatal chronic lung disease (CLD) is associated with long term cardiovascular 
complications. 
3. Pulmonary hypertension complicating CLD is associated with high mortality 
What this study adds: 
1. CLD is associated with relative biventricular dysfunction at 36w CGA. 
2. TDI derived indices may demonstrate evidence of myocardial dysfunction in CLD not 
identified by conventional echocardiographic measurements. 
3. TDI derived RV-IVRT is a potentially useful indirect measure of pulmonary arterial 





FIGURE 1 LEGEND: 
This figure shows the waveform obtained using TDI from Lateral tricuspid annulus.  S’ = peak 
systolic velocity representing systolic function. E’ and A’ = early and late diastolic velocities 
representing diastolic function. MPI = myocardial performance index is calculated from (a-
b/b). a is time interval between the end and beginning of diastolic velocities; b is ejection 
time.  IVCT = isovolumetric contraction time and IVRT = isovolumetric relaxation time. 
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